Tal Zaks (Rodrique Ngowi/AP Images)
Teva recruits Tal Zaks to its board, offering $300K+ pay package and seamless transition from Moderna
Tal Zaks has found the first gig for his post-Moderna career — which will start just right after his last day at the mRNA powerhouse. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.